Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a9057130bebc2a1a84245318386110d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9175c955c29e0123422ff378d2ce3008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_989bcc5862baa744a8b57a9d38c43dd4 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-025 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F5-02 |
filingDate |
1996-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26b404078ae793cada71ae59c6bb0e2b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c38044f5878ef41fc7e25bcf31e481a8 |
publicationDate |
1996-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-9626945-A1 |
titleOfInvention |
Aqueous spectinomycin borate solutions |
abstract |
Aqueous pharmaceutical compositions containing more than 10 % spectinomycin, prepared by the reaction of the ketone hydrate of spectinomycin with boric acid to form the boron compound, and with a base such as sodium hydroxyde to form the stable salt of the compound. Method for preparing same and new boron compound of spectinomycin and salt thereof. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102548552-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6489353-B2 |
priorityDate |
1995-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |